Our Business
Novartis Pharmaceuticals Corporation (NPC) – a US affiliate of Basel, Switzerland-based Novartis AG – researches, develops and markets leading innovative prescription drugs used to treat a broad range of disease areas.
In the US, our products are concentrated in three key areas:
- Cardiovascular & Metabolism
- Specialty Medicines which includes medicines for respiratory diseases, infectious diseases, neuroscience, bone and hormone therapy, ophthalmology, urology, transplantation & immunology
- Oncology
We have quickly achieved a reputation as an industry leader and we continue to grow, expand and evolve our presence in the US.
Who We Are ›
Learn more about Novartis' company history, areas of research and innovation, recent news and awards.
Learn more ›
Leadership ›
Our leadership team, led by Gary Rosenthal consists of respected industry leaders and visionaries who shared a common passion for discovery, innovation and excellence.
Learn more ›
Looking for More Information?
Select a link for information on other Novartis companies.
RESEARCH & DEVELOPMENT
We maintain the most promising pipeline in the industry to treat and help people around the world.
PATIENT ASSISTANCE PROGRAMS
Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.
CLINICAL TRIALS
We are constantly conducting clinical trials to determine the safety and efficacy of new drugs and treatments. The success of these trials relies on patients who volunteer to participate.